Latest autoimmune diseases Stories
SANTA BARBARA, Calif., Jan. 29, 2015 /PRNewswire/ -- VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S.
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
LONDON, January 22, 2015 /PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue
NEW YORK, Jan.
SGM-1019 is an oral small molecule inhibitor of a target identified by company's Microbiome Discovery Platform SOUTH SAN FRANCISCO, Jan.
- Trial results show novel S1P1 modulator produced strong, dose-dependent lymphocyte lowering - SAN DIEGO, Jan. 7, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
Findings supporting novel approaches to inhibit or enhance immune responses for treating autoimmunity and cancer published in Nature Chemical Biology. ANN ARBOR, Mich., Jan.
PRINCETON, N.J., Jan. 5, 2015 /PRNewswire/ -- Soligenix, Inc.
Healthpointe is now offering Blaine Labs products for the prevention of Athlete’s Foot, warts, fungal infections, psoriasis, eczema, foot pain, and other skin, nail, and foot conditions.
- Growing in low tufty patches.